The genetic abnormalities in APOB and MTP are well-established to be associated with the development of familial hypobetalipoproteinemia (FHBL) and abetalipoproteinemia (ABL), respectively (57), both of which are characterized by impaired ApoB secretion. The gene discussed is APOB; the disease is hypobetalipoproteinemia.